San Rafael, Bulacan, Philippines, Oct. 10, 2025 (GLOBE NEWSWIRE) -- One and one Green Technologies. INC (the “Company”) (NASDAQ: YDDL), a waste materials and scrap metal recycling company in the Philippines, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), at a public offering price of $5.00 per share to the public. The Company's Class A Ordinary Shares began trading on the Nasdaq Capital Market on October 9, 2025, under the ticker symbol “YDDL.”

image for news One and One Green Technologies. INC Announces Closing of Initial Public Offering

LOS ANGELES, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PubMatic, Inc., (“PubMatic” or the "Company") (NASDAQ: PUBM) investors off a class action on behalf of investors that bought securities between February 27, 2025 and August 11, 2025, inclusive (the “Class Period”). PubMatic investors have until October 20, 2025 to file a lead plaintiff motion.

image for news Portnoy Law Firm Announces Class Action on Behalf of PubMatic, Inc. Investors

Trump calls off meeting with Xi in South Korea after rare-earth move.

image for news Trump suggests ‘massive increase' of tariffs on China. Here's what's behind the threat.

Can Synchrony Beat Q3 Earnings Estimates on Improving Margins? — Positive

SYF   Zacks Investment Research — October 10, 2025

SYF's Q3 results will likely benefit from wider margins and lower charge-offs, boosting chances of another earnings beat.

image for news Can Synchrony Beat Q3 Earnings Estimates on Improving Margins?

NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- IBM and Script Network, a leading provider of decentralized video infrastructure, today announced that Script Network has officially joined as an IBM Partner as a Preferred Technology Partner. Through this collaboration, Script Network will deliver cutting-edge decentralized video infrastructure, cloud automation, and video data services to IBM-approved clients worldwide.

image for news IBM and Script Network Partner to Deliver Decentralized Video Infrastructure and Automation Services to Global Enterprises

Constellation Brands: Buffett's $2.2B Bet May Have Hit Bottom — Neutral

STZ   MarketBeat — October 10, 2025

Since hitting rock bottom, Warren Buffett's $2.2 billion bet, Constellation Brands NYSE: STZ, has managed to stage a modest recovery. Constellation shares fell to less than $132 in late September.

image for news Constellation Brands: Buffett's $2.2B Bet May Have Hit Bottom

Apogee Enterprises, Inc. (APOG) Q2 2026 Earnings Call Transcript — Neutral

APOG   Seeking Alpha — October 10, 2025

Apogee Enterprises, Inc. (NASDAQ:APOG ) Q2 2026 Earnings Call October 10, 2025 9:00 AM EDT Company Participants Jeremy Steffan Ty Silberhorn - CEO, President & Director Matthew Osberg - Executive VP & CFO Conference Call Participants Brent Thielman - D.A. Davidson & Co., Research Division Julio Romero - Sidoti & Company, LLC Gowshihan Sriharan - Singular Research, LLC Presentation Operator Good day, and thank you for standing by.

image for news Apogee Enterprises, Inc. (APOG) Q2 2026 Earnings Call Transcript

Why ULTA & 3 Retail-Miscellaneous Stocks Could Be the Next Big Winners — Positive

ARHS  SBE  ULTA  WOOF   Zacks Investment Research — October 10, 2025

ULTA, SBH, ARHS & WOOF show resilience in the Retail-Miscellaneous sector as companies adapt to shifting consumer demand with omnichannel platforms, lifestyle-focused products and personalization.

image for news Why ULTA & 3 Retail-Miscellaneous Stocks Could Be the Next Big Winners

5 Low-Leverage Stocks to Buy as Market Takes a Tumble — Positive

CASY  DRS  PNR  RMD  SAFRY   Zacks Investment Research — October 10, 2025

As markets tumble, low-leverage stocks like RMD, SAFRY, PNR, CASY, and DRS offer safer investment options for steady returns.

image for news 5 Low-Leverage Stocks to Buy as Market Takes a Tumble

SJM's Coffee Strength Shines in Q1: What to Expect Through FY26? — Positive

SJM   Zacks Investment Research — October 10, 2025

J.M. Smucker's coffee business fuels gains in Q1, driving a higher FY26 sales outlook despite cost and tariff pressures.

image for news SJM's Coffee Strength Shines in Q1: What to Expect Through FY26?

Fintechs Go Bank Deep: Marsh & McLennan Maps the New Banking Frontier — Positive

MMC   Zacks Investment Research — October 10, 2025

MMC's Oliver Wyman and QED Investors reveal how fintechs gaining bank charters could redefine competition and reshape financial industry dynamics.

image for news Fintechs Go Bank Deep: Marsh & McLennan Maps the New Banking Frontier

Rebranding efforts often come when a company is struggling, but that's not the case for Domino's.

image for news Domino's doubles down on red, white and blue in new logo — and marketing experts take note

Delta, Pepsi, Applied Digital, Levi's, Tilray Brands kick off Q3 earnings season — Neutral

APLD  LEVI  PEP  TLRY   Proactive Investors — October 10, 2025

This week marked the start of earnings season with several major companies reporting results, including Delta Air Lines and PepsiCo, while the big banks like JPMorgan Chase, Citigroup, and Wells Fargo are set to report next week. Investors are closely watching these early reports for cues on the broader economic landscape amid ongoing uncertainties.

image for news Delta, Pepsi, Applied Digital, Levi's, Tilray Brands kick off Q3 earnings season

OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data — Positive

OVID   Zacks Investment Research — October 10, 2025

Ovid Therapeutics jumps 39% in a month after phase I epilepsy study data show superior efficacy of its lead candidate, OV329, hinting at best-in-class potential.

image for news OVID Stock Soars 39% in a Month Following Upbeat Epilepsy Study Data

How Will Whirlpool's Focus on Cost Control & Innovation Boost Profitability? — Positive

WHR   Zacks Investment Research — October 10, 2025

WHR's disciplined cost control and bold product innovation aim to build resilience and fuel sustainable long-term profitability.

image for news How Will Whirlpool's Focus on Cost Control & Innovation Boost Profitability?

Is the Options Market Predicting a Spike in Birkenstock Holding PLC Stock? — Neutral

BIRK   Zacks Investment Research — October 10, 2025

Investors need to pay close attention to Birkenstock Holding PLC stock based on the movements in the options market lately.

image for news Is the Options Market Predicting a Spike in Birkenstock Holding PLC Stock?

China Hits NVDA & QCOM with New Headwinds — Negative

NVDA  QCOM   Schwab Network — October 10, 2025

China has launched an investigation into Qualcomm (QCOM) for what it calls a violation of anti-monopoly laws. Jenny Horne explains how it's just the latest development to counter U.S. tech, adding that Nvidia (NVDA) will face tightened restrictions as well.

image for news China Hits NVDA & QCOM with New Headwinds

Datavault AI Regains Compliance with Nasdaq Minimum Bid Price Requirement — Neutral

DVLT   GlobeNewsWire — October 10, 2025

BEAVERTON, Ore., Oct. 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (Nasdaq: DVLT), a leader in secure data tokenization and Web 3.0 innovations, today announced that it has received official notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) relating to the minimum bid price requirement for its common stock.

image for news Datavault AI Regains Compliance with Nasdaq Minimum Bid Price Requirement

SMR Up 13% in Three Months: Should You Buy, Sell, or Hold the Stock? — Neutral

SMR   Zacks Investment Research — October 10, 2025

NuScale Power's SMR technology gains traction with NRC approvals and major partnerships, but competition and valuation risks keep the stock in check.

image for news SMR Up 13% in Three Months: Should You Buy, Sell, or Hold the Stock?

Johnson & Johnson is in discussions to buy Protagonist Therapeutics , the Wall Street Journal reported on Friday, citing people familiar with the matter.

image for news Johnson & Johnson in talks to acquire Protagonist Therapeutics, WSJ reports